• Galactose-1-Phosphate Uridyltransferase, Blood
  • Oncuria®, Multiplex Biomarker Immunoassay for Bladder Cancer, Urine
  • 1,3-Beta-D-Glucan (Fungitell® ß-D Glucan), Serum
  • Lorazepam, Urine
  • DNA Methylation Gene Panel for Barrett's Esophagus (EndoSign®)
  • Anthrax DNA by Molecular Method
  • Branched-chain-ketoacid dehydrogenase (BCKDH) Gene Mutation Analysis
  • Legionella Culture
  • Ethyl Glucuronide Confirmation, Urine
  • Human T-Cell Lymphotropic Virus (HTLV) I/II Antibody Confirmation
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /CEBPA (CCAAT enhancer binding protein alpha) Gene Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

CEBPA (CCAAT enhancer binding protein alpha) Gene Mutation Analysis
Medical Test

CPT
Access to CEBPA (CCAAT enhancer binding protein alpha) Gene Mutation Analysis is restricted.
Loading...